I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A phase III randomized study to evaluate the efficacy and s..:
Yoo, Dae
;
Racewicz, Artur
;
Brzezicki, Jan
...
http://arthritis-research.com/content/18/1/82. , 2016
Link:
http://arthritis-research.com/content/18/1/82
RT Journal T1
A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study
UL https://suche.suub.uni-bremen.de/peid=base-ftbiomed:oai:biomedcentral.com:s13075-016-0981-6&Exemplar=1&LAN=DE A1 Yoo, Dae A1 Racewicz, Artur A1 Brzezicki, Jan A1 Yatsyshyn, Roman A1 Arteaga, Edgardo A1 Baranauskaite, Asta A1 Abud-Mendoza, Carlos A1 Navarra, Sandra A1 Kadinov, Vladimir A1 Sariego, Irmgadt A1 Hong, Seung A1 Lee, Sung A1 Park, Won PB BioMed Central Ltd. YR 2016 K1 Biosimilar K1 CT-P13 K1 Infliximab K1 Rheumatoid arthritis K1 Efficacy K1 Immunogenicity K1 Safety K1 Pharmacokinetics K1 ACR20 K1 Sharp score JF http://arthritis-research.com/content/18/1/82 LK http://arthritis-research.com/content/18/1/82 DO http://arthritis-research.com/content/18/1/82 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)